Pathology EMQ template.
Name:
Candidate number:
Theme: Immune Therapies
OPTION LIST
|
A |
Efalizumab |
I |
Tacrolimus |
|
B |
Abatecept |
J |
Basiliximab |
|
C |
Rituximab |
K |
Ustekinumab |
|
D |
Infliximab |
L |
Denosumab |
|
E |
Etanercept |
M |
|
|
F |
Azathioprine |
N |
|
|
G |
Mycophenolate mofetil |
O |
|
|
H |
Ciclosporin |
P |
|
For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.
1. Which anti-proliferative agent has a particular risk of herpes virus reactivation?
2. Which immunosuppressant is an antibody to CD20?
3. Which immunosuppressant can cause avascular necrosis of the jaw?
4. Which immunosuppressant is a CTLA4 fusion protein to block CD28?
5. Which immunosuppressant is an antibody to two interleukins?
ANSWERS
|
1. G |
2. C |
3. L |
4. B |
5. K |